LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE
Active substance: EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE ANHYDROUS
INJECTION, SOLUTION · EPINEPHRINE BITARTRATE .005 mg/mL, LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mL
United StatesActive
Marketing holder: HF Acquisition Co LLC, DBA HealthFirst
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- EPINEPHRINE BITARTRATE · .005 mg/mL
- LIDOCAINE HYDROCHLORIDE ANHYDROUS · 20 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-ad19-7445-bbad-fb026e53e9cd,01a12090-84ef-7f1f-a683-afeb06b05e5f;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 51662-1412
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Sources
- product · openFDA NDC · 51662-1412 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 51662-1412 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 51662-1412 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 51662-1412 · Verified 2026-10-09 · open in source